Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ritter

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.
Neuro-Oncology|March 5, 2026
Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma PatientsZaira Seferbekova, Michael Ritter, Gleb Ruckhovich, et al.
Papillomavirus Research (Amsterdam, Netherlands)|December 23, 2017
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young womenÁngela María Ruiz-Sternberg, Edson D Moreira, Jaime A Restrepo, et al.
Nature Cancer|January 29, 2025
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnosticsMichael Ritter, Christina Blume, Yiheng Tang, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
Lancet (London, England)|September 10, 2017
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trialWarner K Huh, Elmar A Joura, Anna R Giuliano, et al.
Nature Medicine|March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumorsAreeba Patel, Kirsten Göbel, Sebastian Ille, et al.
Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.
Neuro-Oncology|March 5, 2026
Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma PatientsZaira Seferbekova, Michael Ritter, Gleb Ruckhovich, et al.
Papillomavirus Research (Amsterdam, Netherlands)|December 23, 2017
Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young womenÁngela María Ruiz-Sternberg, Edson D Moreira, Jaime A Restrepo, et al.
Nature Cancer|January 29, 2025
Spatially resolved transcriptomics and graph-based deep learning improve accuracy of routine CNS tumor diagnosticsMichael Ritter, Christina Blume, Yiheng Tang, et al.
The New England Journal of Medicine|February 19, 2015
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenElmar A Joura, Anna R Giuliano, Ole-Erik Iversen, et al.
Lancet (London, England)|September 10, 2017
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trialWarner K Huh, Elmar A Joura, Anna R Giuliano, et al.
Nature Medicine|March 26, 2025
Prospective, multicenter validation of a platform for rapid molecular profiling of central nervous system tumorsAreeba Patel, Kirsten Göbel, Sebastian Ille, et al.
Nature Genetics|February 9, 2026
A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classificationSybren L N Maas, Yiheng Tang, Eric Stutheit-Zhao, et al.
Pageof 4